Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
XORTX Therapeutics Inc.
XORTX Announces Closing of US$5 Million Public Offering
May 22, 2026
XORTX Announces US$5 Million Public Offering
May 21, 2026
XORTX Meets Nasdaq Continued Listing Requirements
April 23, 2026
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
April 15, 2026
XORTX Confirms Effective Date of Share Consolidation
April 2, 2026
XORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting
March 28, 2026
XORTX Announces Share Consolidation
March 28, 2026
XORTX Announces Results of Annual and Special Meeting of Shareholders
March 28, 2026
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders
March 18, 2026
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation
March 13, 2026